FREE Account Opening + No Clearing Fees
Loading...

Ganga Pharmaceuticals IPO vs Wealth First NSE SME IPO

Comparision between Ganga Pharmaceuticals IPO and Wealth First NSE SME IPO.

IPO Details

Ganga Pharmaceuticals IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Wealth First NSE SME IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Ganga Pharmaceuticals IPO Wealth First NSE SME IPO
Logo Ganga Pharmaceuticals IPO Logo Wealth First NSE SME IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers First Overseas Capital Limited Sarthi Capital Advisors Private Limited
Registrar Kfin Technologies Limited Bigshare Services Pvt Ltd
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL

Issue Size and Price

The total issue size of Ganga Pharmaceuticals IPO is up to ₹1.54 Cr whereas the issue size of the Wealth First NSE SME IPO is up to ₹8.40 Cr. The final issue price of Ganga Pharmaceuticals IPO is ₹15.00 per share and of Wealth First NSE SME IPO is ₹50.00 per share.

  Ganga Pharmaceuticals IPO Wealth First NSE SME IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹15.00 per share ₹50.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 8000 shares 3000 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 10,24,000 shares 16,80,000 shares
Issue Size Total (Amount) up to ₹1.54 Cr up to ₹8.40 Cr

IPO Timetable

Ganga Pharmaceuticals IPO opens on Jan 29, 2016, while Wealth First NSE SME IPO opens on Mar 10, 2016. The closing date of Ganga Pharmaceuticals IPO and Wealth First NSE SME IPO is Feb 09, 2016, and Mar 18, 2016, respectively.

  Ganga Pharmaceuticals IPO Wealth First NSE SME IPO
Anchor Bid Date
Issue Open Jan 29, 2016 Mar 10, 2016
Issue Close Feb 09, 2016 Mar 18, 2016
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Ganga Pharmaceuticals IPO P/E ratio is , as compared to Wealth First NSE SME IPO P/E ratio of .

  Ganga Pharmaceuticals IPO Wealth First NSE SME IPO
Financial
Promoter Shareholding (Pre-Issue) 91.05%
Promoter Shareholding (Post-Issue) 68.09%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW 1.27%%

Shares Offered

In the Ganga Pharmaceuticals IPO retail investors (RII) are offered while in Wealth First NSE SME IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Ganga Pharmaceuticals IPO and in Wealth First NSE SME IPO.

  Ganga Pharmaceuticals IPO Wealth First NSE SME IPO
Anchor Investor Reserveration
Market Maker Reserveration 56,000 shares
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Ganga Pharmaceuticals IPO subscribed in total, whereas Wealth First NSE SME IPO subscribed .

  Ganga Pharmaceuticals IPO Wealth First NSE SME IPO
QIB (times)
NII (times)
Big NII (times)
Small NII (times)
RII (times)
Employee (times)
Other (times)
Total (times)

Comments

Add a public comment...